10-Q Filing

SWK Holdings Corp CIK: 1089907 Q2 2024

Filing Information

Form Type	10-Q
Accession Number	`0001552781-24-000488`
Period End Date	20240630
Filing Date	20240814
Fiscal Year	2024
Fiscal Period	Q2
XBRL Instance	e24328_swkh-10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 166 Income Statement 204 Cash Flow Statement 198 Stockholders Equity 66

Balance Sheet 166 line items

Line Item	Tag	Value	Unit	Period
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$11.85M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$11.85M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$11.10M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$11.10M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$13.08M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$13.08M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$13.90M	USD	Point-in-time
Financing Receivable, Allowance for Credit Loss	`FinancingReceivableAllowanceForCreditLosses`	$13.90M	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.50M	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.55M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.55M	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Restricted cash	`RestrictedCashEquivalentsCurrent`	-	USD	Point-in-time
Restricted cash	`RestrictedCashEquivalentsCurrent`	-	USD	Point-in-time
Restricted cash	`RestrictedCashEquivalentsCurrent`	$733.00K	USD	Point-in-time
Restricted cash	`RestrictedCashEquivalentsCurrent`	$733.00K	USD	Point-in-time
Interest, accounts receivable and other receivables, net	`AccountsReceivableNet`	$4.73M	USD	Point-in-time
Interest, accounts receivable and other receivables, net	`AccountsReceivableNet`	$4.73M	USD	Point-in-time
Interest, accounts receivable and other receivables, net	`AccountsReceivableNet`	$7.38M	USD	Point-in-time
Interest, accounts receivable and other receivables, net	`AccountsReceivableNet`	$7.38M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.86M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.86M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.90M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.90M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$11.87M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$11.87M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$14.79M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$14.79M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	12.45M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	12.45M	shares	Point-in-time
Finance receivables, net of allowance for credit losses of $13,083 and $13,901 as of June 30, 2024 and December 31, 2023, respectively	`NotesAndLoansReceivableNetCurrent`	$265.47M	USD	Point-in-time
Finance receivables, net of allowance for credit losses of $13,083 and $13,901 as of June 30, 2024 and December 31, 2023, respectively	`NotesAndLoansReceivableNetCurrent`	$265.47M	USD	Point-in-time
Finance receivables, net of allowance for credit losses of $13,083 and $13,901 as of June 30, 2024 and December 31, 2023, respectively	`NotesAndLoansReceivableNetCurrent`	$274.50M	USD	Point-in-time
Finance receivables, net of allowance for credit losses of $13,083 and $13,901 as of June 30, 2024 and December 31, 2023, respectively	`NotesAndLoansReceivableNetCurrent`	$274.50M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	12.50M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	12.50M	shares	Point-in-time
Finance receivables, net of allowance for credit losses of $13,083 and $13,901 as of June 30, 2024 and December 31, 2023, respectively	`NotesAndLoansReceivableNetCurrent`	$261.27M	USD	Point-in-time
Finance receivables, net of allowance for credit losses of $13,083 and $13,901 as of June 30, 2024 and December 31, 2023, respectively	`NotesAndLoansReceivableNetCurrent`	$261.27M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	12.50M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	12.50M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	12.45M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	12.45M	shares	Point-in-time
Collateral on foreign currency forward contract	`DerivativeInstrumentsAndHedges`	$2.75M	USD	Point-in-time
Collateral on foreign currency forward contract	`DerivativeInstrumentsAndHedges`	$2.75M	USD	Point-in-time
Collateral on foreign currency forward contract	`DerivativeInstrumentsAndHedges`	$2.75M	USD	Point-in-time
Collateral on foreign currency forward contract	`DerivativeInstrumentsAndHedges`	$2.75M	USD	Point-in-time
Marketable investments	`AvailableForSaleSecuritiesDebtSecurities`	$731.00K	USD	Point-in-time
Marketable investments	`AvailableForSaleSecuritiesDebtSecurities`	$731.00K	USD	Point-in-time
Marketable investments	`AvailableForSaleSecuritiesDebtSecurities`	$48.00K	USD	Point-in-time
Marketable investments	`AvailableForSaleSecuritiesDebtSecurities`	$48.00K	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$27.05M	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$27.05M	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$28.29M	USD	Point-in-time
Deferred tax assets, net	`DeferredIncomeTaxAssetsNet`	$28.29M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$1.76M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$1.76M	USD	Point-in-time
Warrant assets	`WarrantAssets`	$835.00K	USD	Point-in-time
Warrant assets	`WarrantAssets`	$835.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$232.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$232.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.49M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$6.49M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.44M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.44M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.01M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.01M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.11M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.11M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.50M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.50M	USD	Point-in-time
Total assets	`Assets`	$322.34M	USD	Point-in-time
Total assets	`Assets`	$322.34M	USD	Point-in-time
Total assets	`Assets`	$321.37M	USD	Point-in-time
Total assets	`Assets`	$321.37M	USD	Point-in-time
Total assets	`Assets`	$334.25M	USD	Point-in-time
Total assets	`Assets`	$334.25M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.94M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.94M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.31M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.31M	USD	Point-in-time
Deferred income	`DeferredIncomeCurrent`	$2.22M	USD	Point-in-time
Deferred income	`DeferredIncomeCurrent`	$2.22M	USD	Point-in-time
Deferred income	`DeferredIncomeCurrent`	$9.00K	USD	Point-in-time
Deferred income	`DeferredIncomeCurrent`	$9.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.94M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.53M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.53M	USD	Point-in-time
Contingent consideration payable	`ContingentConsiderationClassifiedAsEquityFairValueDisclosure`	-	USD	Point-in-time
Contingent consideration payable	`ContingentConsiderationClassifiedAsEquityFairValueDisclosure`	-	USD	Point-in-time
Contingent consideration payable	`ContingentConsiderationClassifiedAsEquityFairValueDisclosure`	$4.90M	USD	Point-in-time
Contingent consideration payable	`ContingentConsiderationClassifiedAsEquityFairValueDisclosure`	$4.90M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredDebt`	$30.78M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredDebt`	$30.78M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredDebt`	$31.08M	USD	Point-in-time
Unsecured senior notes, net	`UnsecuredDebt`	$31.08M	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	-	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	-	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	$12.35M	USD	Point-in-time
Revolving credit facility	`LongTermLineOfCredit`	$12.35M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.96M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.96M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.57M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.57M	USD	Point-in-time
Total liabilities	`Liabilities`	$38.17M	USD	Point-in-time
Total liabilities	`Liabilities`	$38.17M	USD	Point-in-time
Total liabilities	`Liabilities`	$53.94M	USD	Point-in-time
Total liabilities	`Liabilities`	$53.94M	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,447,195 and 12,497,770 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,447,195 and 12,497,770 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,447,195 and 12,497,770 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,447,195 and 12,497,770 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$12.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.42B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.42B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.43B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$4.43B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.14B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.14B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.14B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.14B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.14B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-4.14B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$273.88M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$273.88M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$279.55M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$279.55M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$283.20M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$283.20M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$279.93M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$279.93M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$280.31M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$280.31M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$274.38M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$274.38M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$321.37M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$321.37M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$334.25M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$334.25M	USD	Point-in-time

Income Statement 204 line items

Line Item	Tag	Value	Unit	Period
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$10.68M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$10.68M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$18.54M	USD	2 Qtrs
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$18.54M	USD	2 Qtrs
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$9.28M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$9.28M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$10.72M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$10.72M	USD	1 Quarter
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$21.40M	USD	2 Qtrs
Finance receivable interest income, including fees	`InterestAndFeeIncomeLoansAndLeases`	$21.40M	USD	2 Qtrs
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$301.00K	USD	2 Qtrs
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$301.00K	USD	2 Qtrs
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$183.00K	USD	1 Quarter
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$183.00K	USD	1 Quarter
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$279.00K	USD	1 Quarter
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$279.00K	USD	1 Quarter
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$804.00K	USD	1 Quarter
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$804.00K	USD	1 Quarter
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$1.08M	USD	2 Qtrs
Pharmaceutical development	`PharmaceuticalDevelopmentRevenue`	$1.08M	USD	2 Qtrs
Other	`RevenueNotFromContractWithCustomerOther`	$103.00K	USD	2 Qtrs
Other	`RevenueNotFromContractWithCustomerOther`	$103.00K	USD	2 Qtrs
Other	`RevenueNotFromContractWithCustomerOther`	$57.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomerOther`	$57.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomerOther`	$69.00K	USD	2 Qtrs
Other	`RevenueNotFromContractWithCustomerOther`	$69.00K	USD	2 Qtrs
Other	`RevenueNotFromContractWithCustomerOther`	$46.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomerOther`	$46.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomerOther`	$36.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomerOther`	$36.00K	USD	1 Quarter
Total revenues	`Revenues`	$22.59M	USD	2 Qtrs
Total revenues	`Revenues`	$22.59M	USD	2 Qtrs
Total revenues	`Revenues`	$9.50M	USD	1 Quarter
Total revenues	`Revenues`	$9.50M	USD	1 Quarter
Total revenues	`Revenues`	$18.91M	USD	2 Qtrs
Total revenues	`Revenues`	$18.91M	USD	2 Qtrs
Total revenues	`Revenues`	$11.54M	USD	1 Quarter
Total revenues	`Revenues`	$11.54M	USD	1 Quarter
Total revenues	`Revenues`	$11.04M	USD	1 Quarter
Total revenues	`Revenues`	$11.04M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$4.07M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$4.07M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-682.00K	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-682.00K	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-682.00K	USD	2 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-682.00K	USD	2 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$9.40M	USD	2 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$9.40M	USD	2 Qtrs
Loss on impairment of intangibles assets	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Loss on impairment of intangibles assets	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Loss on impairment of intangibles assets	`GoodwillImpairmentLoss`	$5.77M	USD	1 Quarter
Loss on impairment of intangibles assets	`GoodwillImpairmentLoss`	$5.77M	USD	1 Quarter
Loss on impairment of intangibles assets	`GoodwillImpairmentLoss`	$5.77M	USD	2 Qtrs
Loss on impairment of intangibles assets	`GoodwillImpairmentLoss`	$5.77M	USD	2 Qtrs
Loss on impairment of intangibles assets	`GoodwillImpairmentLoss`	-	USD	2 Qtrs
Loss on impairment of intangibles assets	`GoodwillImpairmentLoss`	-	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.12M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.12M	USD	1 Quarter
Interest expense	`InterestExpense`	$363.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$363.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$545.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$545.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$2.38M	USD	2 Qtrs
Interest expense	`InterestExpense`	$2.38M	USD	2 Qtrs
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$1.51M	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$1.51M	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$520.00K	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$520.00K	USD	1 Quarter
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$1.05M	USD	2 Qtrs
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$1.05M	USD	2 Qtrs
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$2.23M	USD	2 Qtrs
Pharmaceutical manufacturing, research and development expense	`ResearchAndDevelopmentExpense`	$2.23M	USD	2 Qtrs
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	$-4.90M	USD	1 Quarter
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	$-4.90M	USD	1 Quarter
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	-	USD	1 Quarter
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	-	USD	1 Quarter
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	$-4.90M	USD	2 Qtrs
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	$-4.90M	USD	2 Qtrs
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	-	USD	2 Qtrs
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	-	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationAndAmortization`	$1.28M	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationAndAmortization`	$1.28M	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationAndAmortization`	$421.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationAndAmortization`	$421.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationAndAmortization`	$637.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationAndAmortization`	$637.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationAndAmortization`	$935.00K	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationAndAmortization`	$935.00K	USD	2 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$2.92M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$2.92M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$5.61M	USD	2 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$5.61M	USD	2 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$5.54M	USD	2 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$5.54M	USD	2 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$3.00M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$3.00M	USD	1 Quarter
Income from operations	`CostsAndExpenses`	$-1.61M	USD	1 Quarter
Income from operations	`CostsAndExpenses`	$-1.61M	USD	1 Quarter
Income from operations	`CostsAndExpenses`	$-4.67M	USD	1 Quarter
Income from operations	`CostsAndExpenses`	$-4.67M	USD	1 Quarter
Income from operations	`CostsAndExpenses`	$-2.35M	USD	2 Qtrs
Income from operations	`CostsAndExpenses`	$-2.35M	USD	2 Qtrs
Income from operations	`CostsAndExpenses`	$-9.99M	USD	2 Qtrs
Income from operations	`CostsAndExpenses`	$-9.99M	USD	2 Qtrs
Unrealized net gain (loss) on warrants	`UnrealizedGainLossOnDerivatives`	$399.00K	USD	1 Quarter
Unrealized net gain (loss) on warrants	`UnrealizedGainLossOnDerivatives`	$399.00K	USD	1 Quarter
Unrealized net gain (loss) on warrants	`UnrealizedGainLossOnDerivatives`	$-583.00K	USD	2 Qtrs
Unrealized net gain (loss) on warrants	`UnrealizedGainLossOnDerivatives`	$-583.00K	USD	2 Qtrs
Unrealized net gain (loss) on warrants	`UnrealizedGainLossOnDerivatives`	$226.00K	USD	1 Quarter
Unrealized net gain (loss) on warrants	`UnrealizedGainLossOnDerivatives`	$226.00K	USD	1 Quarter
Unrealized net gain (loss) on warrants	`UnrealizedGainLossOnDerivatives`	$131.00K	USD	2 Qtrs
Unrealized net gain (loss) on warrants	`UnrealizedGainLossOnDerivatives`	$131.00K	USD	2 Qtrs
Net realized gain on sale of marketable investments	`NetRealizedGainOnExerciseOfWarrants`	$656.00K	USD	1 Quarter
Net realized gain on sale of marketable investments	`NetRealizedGainOnExerciseOfWarrants`	$656.00K	USD	1 Quarter
Net realized gain on sale of marketable investments	`NetRealizedGainOnExerciseOfWarrants`	$513.00K	USD	2 Qtrs
Net realized gain on sale of marketable investments	`NetRealizedGainOnExerciseOfWarrants`	$513.00K	USD	2 Qtrs
Net realized gain on sale of marketable investments	`NetRealizedGainOnExerciseOfWarrants`	-	USD	1 Quarter
Net realized gain on sale of marketable investments	`NetRealizedGainOnExerciseOfWarrants`	-	USD	1 Quarter
Net realized gain on sale of marketable investments	`NetRealizedGainOnExerciseOfWarrants`	-	USD	2 Qtrs
Net realized gain on sale of marketable investments	`NetRealizedGainOnExerciseOfWarrants`	-	USD	2 Qtrs
Realized gain (loss) on sale of assets	`GainLossOnDispositionOfAssets1`	$3.00K	USD	1 Quarter
Realized gain (loss) on sale of assets	`GainLossOnDispositionOfAssets1`	$3.00K	USD	1 Quarter
Realized gain (loss) on sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	2 Qtrs
Realized gain (loss) on sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	2 Qtrs
Realized gain (loss) on sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Realized gain (loss) on sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Realized gain (loss) on sale of assets	`GainLossOnDispositionOfAssets1`	$-228.00K	USD	2 Qtrs
Realized gain (loss) on sale of assets	`GainLossOnDispositionOfAssets1`	$-228.00K	USD	2 Qtrs
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$2.50M	USD	1 Quarter
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$2.50M	USD	1 Quarter
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	1 Quarter
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	1 Quarter
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$2.50M	USD	2 Qtrs
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$2.50M	USD	2 Qtrs
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	2 Qtrs
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	2 Qtrs
Realized and unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainBeforeTax`	$316.00K	USD	1 Quarter
Realized and unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainBeforeTax`	$316.00K	USD	1 Quarter
Realized and unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainBeforeTax`	$437.00K	USD	1 Quarter
Realized and unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainBeforeTax`	$437.00K	USD	1 Quarter
Realized and unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainBeforeTax`	$502.00K	USD	2 Qtrs
Realized and unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainBeforeTax`	$502.00K	USD	2 Qtrs
Realized and unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainBeforeTax`	$524.00K	USD	2 Qtrs
Realized and unrealized foreign currency transaction gains	`ForeignCurrencyTransactionGainBeforeTax`	$524.00K	USD	2 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$5.39M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$5.39M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$9.91M	USD	2 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$9.91M	USD	2 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$5.79M	USD	2 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$5.79M	USD	2 Qtrs
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$5.43M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$5.43M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.03M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.03M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.26M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$1.26M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$1.45M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.45M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.34M	USD	2 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	$1.34M	USD	2 Qtrs
Net income	`ProfitLoss`	$3.93M	USD	1 Quarter
Net income	`ProfitLoss`	$3.93M	USD	1 Quarter
Net income	`ProfitLoss`	$4.39M	USD	1 Quarter
Net income	`ProfitLoss`	$4.39M	USD	1 Quarter
Net income	`ProfitLoss`	$8.57M	USD	2 Qtrs
Net income	`ProfitLoss`	$8.57M	USD	2 Qtrs
Net income	`ProfitLoss`	$4.52M	USD	2 Qtrs
Net income	`ProfitLoss`	$4.52M	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.36	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.36	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.67	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.67	USD	2 Qtrs
Basic	`EarningsPerShareBasic`	$0.01	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.01	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.31	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.31	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.35	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.35	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.31	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.31	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.36	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.36	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.67	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.67	USD	2 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.35	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.35	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.01	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.01	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.46M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.46M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.74M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.74M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.79M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.79M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.47M	shares	2 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.47M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.79M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.79M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.53M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.53M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.53M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.53M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.83M	shares	2 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.83M	shares	2 Qtrs

Cash Flow Statement 198 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$3.93M	USD	1 Quarter
Net income	`ProfitLoss`	$3.93M	USD	1 Quarter
Net income	`ProfitLoss`	$4.39M	USD	1 Quarter
Net income	`ProfitLoss`	$4.39M	USD	1 Quarter
Net income	`ProfitLoss`	$8.57M	USD	2 Qtrs
Net income	`ProfitLoss`	$8.57M	USD	2 Qtrs
Net income	`ProfitLoss`	$4.52M	USD	2 Qtrs
Net income	`ProfitLoss`	$4.52M	USD	2 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$4.07M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$4.07M	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-682.00K	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-682.00K	USD	1 Quarter
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-682.00K	USD	2 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$-682.00K	USD	2 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$9.40M	USD	2 Qtrs
Provision (benefit) for credit losses	`ProvisionForOtherCreditLosses`	$9.40M	USD	2 Qtrs
Loss on impairment of intangible assets	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Loss on impairment of intangible assets	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Loss on impairment of intangible assets	`GoodwillImpairmentLoss`	$5.77M	USD	1 Quarter
Loss on impairment of intangible assets	`GoodwillImpairmentLoss`	$5.77M	USD	1 Quarter
Loss on impairment of intangible assets	`GoodwillImpairmentLoss`	$5.77M	USD	2 Qtrs
Loss on impairment of intangible assets	`GoodwillImpairmentLoss`	$5.77M	USD	2 Qtrs
Loss on impairment of intangible assets	`GoodwillImpairmentLoss`	-	USD	2 Qtrs
Loss on impairment of intangible assets	`GoodwillImpairmentLoss`	-	USD	2 Qtrs
Right-of-use amortization and cease use costs	`FinanceLeaseRightOfUseAssetAmortization`	$156.00K	USD	2 Qtrs
Right-of-use amortization and cease use costs	`FinanceLeaseRightOfUseAssetAmortization`	$156.00K	USD	2 Qtrs
Right-of-use amortization and cease use costs	`FinanceLeaseRightOfUseAssetAmortization`	$261.00K	USD	2 Qtrs
Right-of-use amortization and cease use costs	`FinanceLeaseRightOfUseAssetAmortization`	$261.00K	USD	2 Qtrs
Amortization of debt issuance costs	`NoncashInterestExpense`	$491.00K	USD	2 Qtrs
Amortization of debt issuance costs	`NoncashInterestExpense`	$491.00K	USD	2 Qtrs
Amortization of debt issuance costs	`NoncashInterestExpense`	$168.00K	USD	2 Qtrs
Amortization of debt issuance costs	`NoncashInterestExpense`	$168.00K	USD	2 Qtrs
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$1.32M	USD	2 Qtrs
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$1.32M	USD	2 Qtrs
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$1.24M	USD	2 Qtrs
Deferred income taxes, net	`DeferredIncomeTaxesAndTaxCredits`	$1.24M	USD	2 Qtrs
Net change in fair value of warrant assets	`UnrealizedGainLossOnDerivatives`	$399.00K	USD	1 Quarter
Net change in fair value of warrant assets	`UnrealizedGainLossOnDerivatives`	$399.00K	USD	1 Quarter
Net change in fair value of warrant assets	`UnrealizedGainLossOnDerivatives`	$-583.00K	USD	2 Qtrs
Net change in fair value of warrant assets	`UnrealizedGainLossOnDerivatives`	$-583.00K	USD	2 Qtrs
Net change in fair value of warrant assets	`UnrealizedGainLossOnDerivatives`	$226.00K	USD	1 Quarter
Net change in fair value of warrant assets	`UnrealizedGainLossOnDerivatives`	$226.00K	USD	1 Quarter
Net change in fair value of warrant assets	`UnrealizedGainLossOnDerivatives`	$131.00K	USD	2 Qtrs
Net change in fair value of warrant assets	`UnrealizedGainLossOnDerivatives`	$131.00K	USD	2 Qtrs
Net realized gain on exercise of warrants	`NetRealizedGainOnExerciseOfWarrants`	$656.00K	USD	1 Quarter
Net realized gain on exercise of warrants	`NetRealizedGainOnExerciseOfWarrants`	$656.00K	USD	1 Quarter
Net realized gain on exercise of warrants	`NetRealizedGainOnExerciseOfWarrants`	$513.00K	USD	2 Qtrs
Net realized gain on exercise of warrants	`NetRealizedGainOnExerciseOfWarrants`	$513.00K	USD	2 Qtrs
Net realized gain on exercise of warrants	`NetRealizedGainOnExerciseOfWarrants`	-	USD	1 Quarter
Net realized gain on exercise of warrants	`NetRealizedGainOnExerciseOfWarrants`	-	USD	1 Quarter
Net realized gain on exercise of warrants	`NetRealizedGainOnExerciseOfWarrants`	-	USD	2 Qtrs
Net realized gain on exercise of warrants	`NetRealizedGainOnExerciseOfWarrants`	-	USD	2 Qtrs
Realized loss from sale of assets	`GainLossOnDispositionOfAssets1`	$3.00K	USD	1 Quarter
Realized loss from sale of assets	`GainLossOnDispositionOfAssets1`	$3.00K	USD	1 Quarter
Realized loss from sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	2 Qtrs
Realized loss from sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	2 Qtrs
Realized loss from sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Realized loss from sale of assets	`GainLossOnDispositionOfAssets1`	-	USD	1 Quarter
Realized loss from sale of assets	`GainLossOnDispositionOfAssets1`	$-228.00K	USD	2 Qtrs
Realized loss from sale of assets	`GainLossOnDispositionOfAssets1`	$-228.00K	USD	2 Qtrs
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	$-4.90M	USD	1 Quarter
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	$-4.90M	USD	1 Quarter
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	-	USD	1 Quarter
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	-	USD	1 Quarter
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	$-4.90M	USD	2 Qtrs
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	$-4.90M	USD	2 Qtrs
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	-	USD	2 Qtrs
Change in fair value of acquisition-related contingent consideration	`ChangeInFairValueOfAcquisitionrelatedContingentConsideration`	-	USD	2 Qtrs
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$2.50M	USD	1 Quarter
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$2.50M	USD	1 Quarter
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	1 Quarter
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	1 Quarter
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$2.50M	USD	2 Qtrs
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	$2.50M	USD	2 Qtrs
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	2 Qtrs
Gain on revaluation of finance receivable	`DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount`	-	USD	2 Qtrs
Foreign currency transaction gain	`ForeignCurrencyTransactionGainLossBeforeTax`	$-327.00K	USD	2 Qtrs
Foreign currency transaction gain	`ForeignCurrencyTransactionGainLossBeforeTax`	$-327.00K	USD	2 Qtrs
Foreign currency transaction gain	`ForeignCurrencyTransactionGainLossBeforeTax`	$-516.00K	USD	2 Qtrs
Foreign currency transaction gain	`ForeignCurrencyTransactionGainLossBeforeTax`	$-516.00K	USD	2 Qtrs
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$-2.59M	USD	2 Qtrs
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$-2.59M	USD	2 Qtrs
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$-2.30M	USD	2 Qtrs
Loan discount amortization and fee accretion	`AmortizationOfDeferredLoanOriginationFeesNet`	$-2.30M	USD	2 Qtrs
Interest paid-in-kind	`PaidInKindInterest`	$904.00K	USD	2 Qtrs
Interest paid-in-kind	`PaidInKindInterest`	$904.00K	USD	2 Qtrs
Interest paid-in-kind	`PaidInKindInterest`	$957.00K	USD	2 Qtrs
Interest paid-in-kind	`PaidInKindInterest`	$957.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$249.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$249.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$164.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$164.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$199.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$199.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$111.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$111.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$360.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$360.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$35.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$35.00K	USD	1 Quarter
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$935.00K	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$935.00K	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.28M	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$1.28M	USD	2 Qtrs
Interest, accounts receivable and other receivables	`IncreaseDecreaseInInterestAndDividendsReceivable`	$-1.29M	USD	2 Qtrs
Interest, accounts receivable and other receivables	`IncreaseDecreaseInInterestAndDividendsReceivable`	$-1.29M	USD	2 Qtrs
Interest, accounts receivable and other receivables	`IncreaseDecreaseInInterestAndDividendsReceivable`	$-2.65M	USD	2 Qtrs
Interest, accounts receivable and other receivables	`IncreaseDecreaseInInterestAndDividendsReceivable`	$-2.65M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$792.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$792.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$150.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$150.00K	USD	2 Qtrs
Accounts payable, accrued expenses, and other non-current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-900.00K	USD	2 Qtrs
Accounts payable, accrued expenses, and other non-current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-900.00K	USD	2 Qtrs
Accounts payable, accrued expenses, and other non-current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-354.00K	USD	2 Qtrs
Accounts payable, accrued expenses, and other non-current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-354.00K	USD	2 Qtrs
Deferred income	`DeferredIncomePeriodIncreaseDecrease`	$-3.00K	USD	2 Qtrs
Deferred income	`DeferredIncomePeriodIncreaseDecrease`	$-3.00K	USD	2 Qtrs
Deferred income	`DeferredIncomePeriodIncreaseDecrease`	$2.21M	USD	2 Qtrs
Deferred income	`DeferredIncomePeriodIncreaseDecrease`	$2.21M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$9.84M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$9.84M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$5.39M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$5.39M	USD	2 Qtrs
Sale of finance receivables	`ProceedsFromSaleOfEquitySecuritiesFvNi`	-	USD	2 Qtrs
Sale of finance receivables	`ProceedsFromSaleOfEquitySecuritiesFvNi`	-	USD	2 Qtrs
Sale of finance receivables	`ProceedsFromSaleOfEquitySecuritiesFvNi`	$13.94M	USD	2 Qtrs
Sale of finance receivables	`ProceedsFromSaleOfEquitySecuritiesFvNi`	$13.94M	USD	2 Qtrs
Sale of marketable investments	`ProceedsFromWarrantExercises`	$574.00K	USD	2 Qtrs
Sale of marketable investments	`ProceedsFromWarrantExercises`	$574.00K	USD	2 Qtrs
Sale of marketable investments	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Sale of marketable investments	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$13.10M	USD	2 Qtrs
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$13.10M	USD	2 Qtrs
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$7.45M	USD	2 Qtrs
Investment in finance receivables	`PaymentsToAcquireFinanceReceivables`	$7.45M	USD	2 Qtrs
Repayment of finance receivables	`ProceedsRepaymentOfFinanceReceivables`	$11.69M	USD	2 Qtrs
Repayment of finance receivables	`ProceedsRepaymentOfFinanceReceivables`	$11.69M	USD	2 Qtrs
Repayment of finance receivables	`ProceedsRepaymentOfFinanceReceivables`	$3.04M	USD	2 Qtrs
Repayment of finance receivables	`ProceedsRepaymentOfFinanceReceivables`	$3.04M	USD	2 Qtrs
Corporate debt securities principal payments	`MarketableInvestmentPrincipalPayment`	$13.00K	USD	2 Qtrs
Corporate debt securities principal payments	`MarketableInvestmentPrincipalPayment`	$13.00K	USD	2 Qtrs
Corporate debt securities principal payments	`MarketableInvestmentPrincipalPayment`	$17.00K	USD	2 Qtrs
Corporate debt securities principal payments	`MarketableInvestmentPrincipalPayment`	$17.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$21.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$21.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$191.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$191.00K	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$4.81M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$4.81M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$3.71M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$3.71M	USD	2 Qtrs
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	$-43.00K	USD	1 Quarter
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	$-43.00K	USD	1 Quarter
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	-	USD	2 Qtrs
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	-	USD	2 Qtrs
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	$-43.00K	USD	2 Qtrs
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	$-43.00K	USD	2 Qtrs
Net payments on credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-2.44M	USD	2 Qtrs
Net payments on credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-2.44M	USD	2 Qtrs
Net payments on credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-12.35M	USD	2 Qtrs
Net payments on credit facility	`ProceedsFromRepaymentsOfLinesOfCredit`	$-12.35M	USD	2 Qtrs
Payments for financing costs	`PaymentsOfFinancingCosts`	-	USD	2 Qtrs
Payments for financing costs	`PaymentsOfFinancingCosts`	-	USD	2 Qtrs
Payments for financing costs	`PaymentsOfFinancingCosts`	$872.00K	USD	2 Qtrs
Payments for financing costs	`PaymentsOfFinancingCosts`	$872.00K	USD	2 Qtrs
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$5.13M	USD	2 Qtrs
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$5.13M	USD	2 Qtrs
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$1.95M	USD	2 Qtrs
Repurchases of common stock, including fees and expenses	`PaymentsForRepurchaseOfCommonStock`	$1.95M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-8.45M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-8.45M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-14.34M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-14.34M	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$649.00K	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$649.00K	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$313.00K	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$313.00K	USD	2 Qtrs
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.55M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.55M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.16M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.16M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.80M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.80M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.55M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.55M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.16M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.16M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.24M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.80M	USD	Point-in-time
Cash, cash equivalents, and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.80M	USD	Point-in-time
Derecognition of right-of-use assets and operating lease liabilities upon termination of lease	`DerecognitionOfRouAssetsToOperatingLeaseLiabilitiesUponTerminationOfLease`	-	USD	2 Qtrs
Derecognition of right-of-use assets and operating lease liabilities upon termination of lease	`DerecognitionOfRouAssetsToOperatingLeaseLiabilitiesUponTerminationOfLease`	-	USD	2 Qtrs
Derecognition of right-of-use assets and operating lease liabilities upon termination of lease	`DerecognitionOfRouAssetsToOperatingLeaseLiabilitiesUponTerminationOfLease`	$82.00K	USD	2 Qtrs
Derecognition of right-of-use assets and operating lease liabilities upon termination of lease	`DerecognitionOfRouAssetsToOperatingLeaseLiabilitiesUponTerminationOfLease`	$82.00K	USD	2 Qtrs

Stockholders Equity 66 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$273.88M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$273.88M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$279.55M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$279.55M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$283.20M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$283.20M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$279.93M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$279.93M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$280.31M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$280.31M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$274.38M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$274.38M	USD	Point-in-time
Stock-based compensation	`ShareBasedCompensation`	$249.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$249.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$164.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$164.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$199.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$199.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$111.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$111.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$360.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$360.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$35.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$35.00K	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Issuance of common stock upon vesting of restricted stock	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Repurchase of common stock in open market	`StockRepurchasedDuringPeriodValue`	$531.00K	USD	1 Quarter
Repurchase of common stock in open market	`StockRepurchasedDuringPeriodValue`	$531.00K	USD	1 Quarter
Repurchase of common stock in open market	`StockRepurchasedDuringPeriodValue`	$4.60M	USD	1 Quarter
Repurchase of common stock in open market	`StockRepurchasedDuringPeriodValue`	$4.60M	USD	1 Quarter
Repurchase of common stock in open market	`StockRepurchasedDuringPeriodValue`	$999.00K	USD	1 Quarter
Repurchase of common stock in open market	`StockRepurchasedDuringPeriodValue`	$999.00K	USD	1 Quarter
Repurchase of common stock in open market	`StockRepurchasedDuringPeriodValue`	$950.00K	USD	1 Quarter
Repurchase of common stock in open market	`StockRepurchasedDuringPeriodValue`	$950.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.93M	USD	1 Quarter
Net income	`NetIncomeLoss`	$3.93M	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.63M	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.63M	USD	1 Quarter
Net income	`NetIncomeLoss`	$126.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$126.00K	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.39M	USD	1 Quarter
Net income	`NetIncomeLoss`	$4.39M	USD	1 Quarter
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	$-43.00K	USD	1 Quarter
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	$-43.00K	USD	1 Quarter
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	-	USD	2 Qtrs
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	-	USD	2 Qtrs
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	$-43.00K	USD	2 Qtrs
Net settlement for employee taxes on stock options	`NetSettlementForEmployeeTaxesOnRestrictedStockAndOptions`	$-43.00K	USD	2 Qtrs
Effect of adoption of ASU 2016-13	`EffectOfAdoptionOfAccountingStandard`	$-9.68M	USD	1 Quarter
Effect of adoption of ASU 2016-13	`EffectOfAdoptionOfAccountingStandard`	$-9.68M	USD	1 Quarter
Ending balance, value	`StockholdersEquity`	$273.88M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$273.88M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$279.55M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$279.55M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$283.20M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$283.20M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$279.93M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$279.93M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$280.31M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$280.31M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$274.38M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$274.38M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.